Best Programmed Death Receptor-1 Blocking Antibody for carcinoma, non-small-cell lung
Top-rated pick: Keytruda — pharmaranks score 72/100, the highest of the 2 Programmed Death Receptor-1 Blocking Antibody drugs used for carcinoma, non-small-cell lung, ranked by our independent FDA recall-safety score. Compare them with all treatments for carcinoma, non-small-cell lung or the full Programmed Death Receptor-1 Blocking Antibody class. Not medical advice — always consult a professional.
Quick answer: Of the 2 programmed death receptor-1 blocking antibody drugs we rate for carcinoma, non-small-cell lung, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for carcinoma, non-small-cell lung; the right choice depends on your situation, so confirm it with your prescriber.
Other drug classes for carcinoma, non-small-cell lung
Top programmed death receptor-1 blocking antibody for carcinoma, non-small-cell lung: 1. Keytruda · 2. Opdivo
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | No data | — | View → | |
| 2 | 72/100 | Prescription | Injectable | No data | — | View → |
Full ranking · 2 drugs
keytruda
PrescriptionFDA-sourced
Keytruda (Pembrolizumab) is a programmed death receptor-1 blocking antibody used to treat Malignant Mesothelioma, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma.
Price varies
opdivo
PrescriptionFDA-sourced
Opdivo (Nivolumab) is a programmed death receptor-1 blocking antibody used to treat Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma, Kidney Neoplasms.
Price varies
Frequently asked
- What is the best programmed death receptor-1 blocking antibody for carcinoma, non-small-cell lung?
- By our independent recall-safety rating — not an efficacy measure — keytruda ranks highest among Programmed Death Receptor-1 Blocking Antibody drugs used for carcinoma, non-small-cell lung. Always consult a professional.
- Which programmed death receptor-1 blocking antibody drugs treat carcinoma, non-small-cell lung?
- pharmaranks lists 2 Programmed Death Receptor-1 Blocking Antibody products used for carcinoma, non-small-cell lung, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status